These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of a new uricosuric diuretic--ticrynafen. Kosman ME JAMA; 1979 Dec; 242(26):2876-8. PubMed ID: 513260 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratio. Tobert JA; Cirillo VJ; Hitzenberger G; James I; Pryor J; Cook T; Buntinx A; Holmes IB; Lutterbeck PM Clin Pharmacol Ther; 1981 Mar; 29(3):344-50. PubMed ID: 7471605 [TBL] [Abstract][Full Text] [Related]
4. The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics. Johnson MW; Mitch WE Drugs; 1981 Mar; 21(3):220-5. PubMed ID: 7261949 [TBL] [Abstract][Full Text] [Related]
5. Enantiomers of indacrinone: a new approach to producing an isouricemic diuretic. Blaine EH; Fanelli GM; Irvin JD; Tobert JA; Davies RO Clin Exp Hypertens A; 1982; 4(1-2):161-76. PubMed ID: 7074983 [TBL] [Abstract][Full Text] [Related]
6. Effects of uricosuric and antiuricosuric agents on urate transport in human brush-border membrane vesicles. Roch-Ramel F; Guisan B; Diezi J J Pharmacol Exp Ther; 1997 Feb; 280(2):839-45. PubMed ID: 9023298 [TBL] [Abstract][Full Text] [Related]
7. Drug induced gout. Semple PF Scott Med J; 1973; 18():Suppl 1:239-42. PubMed ID: 4590061 [No Abstract] [Full Text] [Related]
8. Comparison of ticrynafen and probenecid in patients with elevated uric acid levels. Jain AK; Ryan JR; McMahon FG Nephron; 1979; 23 Suppl 1():46-50. PubMed ID: 381955 [TBL] [Abstract][Full Text] [Related]
9. Dose-response relationship of a uricosuric diuretic. Emmerson BT; Thompson L; Mitchell K Adv Exp Med Biol; 1977; 76B():320-7. PubMed ID: 855758 [No Abstract] [Full Text] [Related]
10. The renal handling of tienilic acid (ticrynafen), a new diuretic with uricosuric properties. Lemieux G; Vinay P; Paquin J; Gougoux A Nephron; 1979; 23 Suppl 1():7-14. PubMed ID: 471154 [No Abstract] [Full Text] [Related]
11. Studies on the mechanism and characteristics of action of a uricosuric diuretic, indacrinone (MK-196). Brooks BA; Blair EM; Finch R; Lant AF Br J Clin Pharmacol; 1980 Sep; 10(3):249-58. PubMed ID: 7437242 [TBL] [Abstract][Full Text] [Related]
12. Effect of tienilic acid and amiloride in healthy volunteers and in hypertensives with normal renal function. Myers JB; Gillies A; Waga S; Morgan TO Br J Clin Pharmacol; 1980 Oct; 10(4):345-51. PubMed ID: 7004473 [No Abstract] [Full Text] [Related]
13. Mechanism of the uricosuric activity of ticrynafen. Steele TH Nephron; 1979; 23 Suppl 1():33-7. PubMed ID: 471151 [TBL] [Abstract][Full Text] [Related]
14. Effects of uricosuric drugs and diuretics on uric acid excretion in oxonate-treated rats. Yonetani Y; Iwaki K Jpn J Pharmacol; 1983 Oct; 33(5):947-54. PubMed ID: 6645117 [TBL] [Abstract][Full Text] [Related]
15. The effects of ticrynafen in the rat. Minor S; Taylor K; Knight TF; Senekjian HO; Weinman EJ Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):53-63. PubMed ID: 451359 [TBL] [Abstract][Full Text] [Related]
16. Indacrinone: modification of diuretic, uricosuric, and kaliuretic actions by amiloride. Ravenscroft PJ; Hall GR; Ahokas JT; Emmerson BT; Tobert JA Clin Pharmacol Ther; 1980 Jul; 28(1):45-51. PubMed ID: 7389253 [TBL] [Abstract][Full Text] [Related]
17. Ticrynafen: a new thiazide-like but uricosuric antihypertensive diuretic. Frohlich ED N Engl J Med; 1979 Dec; 301(25):1378-82. PubMed ID: 503168 [No Abstract] [Full Text] [Related]
18. Renal sites of natriuretic and uricosuric activity of ticrynafen in the mongrel dog. Snow IB; Maass AR Nephron; 1979; 23 Suppl 1():15-20. PubMed ID: 471147 [TBL] [Abstract][Full Text] [Related]
19. Renal function during therapy in patients with congestive cardiac failure. Ticrynafen vs. hydrochlorothiazide. Smith JW; Clements P Nephron; 1979; 23 Suppl 1():41-5. PubMed ID: 381954 [TBL] [Abstract][Full Text] [Related]